Cargando…
Galectin-3 is related to right ventricular dysfunction in heart failure patients with reduced ejection fraction and may affect exercise capacity
Galectin-3 is a biomarker of fibrosis, inflammation and oxidative stress, and its role in heart remodelling and exercise intolerance has not been conclusively proven in heart failure (HF) patients with reduced ejection fraction (rEF). We prospectively assessed 67 consecutive patients with symptomati...
Autores principales: | Zaborska, Beata, Sygitowicz, Grażyna, Smarż, Krzysztof, Pilichowska-Paszkiet, Ewa, Budaj, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542167/ https://www.ncbi.nlm.nih.gov/pubmed/33028850 http://dx.doi.org/10.1038/s41598-020-73634-8 |
Ejemplares similares
-
The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
por: Zaborska, Beata, et al.
Publicado: (2023) -
Prognostic value of galectin-3 and right ventricular function for long-term mortality in heart failure patients treated with cardiac resynchronization therapy
por: Zaborska, Beata, et al.
Publicado: (2021) -
Chronotropic Incompetence Limits Aerobic Exercise Capacity in Patients Taking Beta-Blockers: Real-Life Observation of Consecutive Patients
por: Smarz, Krzysztof, et al.
Publicado: (2021) -
Echocardiographic predictors of exercise intolerance in patients with heart failure with severely reduced ejection fraction
por: Zaborska, Beata, et al.
Publicado: (2018) -
Mechanisms of Exercise Capacity Improvement after Cardiac Rehabilitation Following Myocardial Infarction Assessed with Combined Stress Echocardiography and Cardiopulmonary Exercise Testing
por: Smarz, Krzysztof, et al.
Publicado: (2021)